DEINOVE is a France-based biotechnology company that researches and develops antimicrobial therapies for the treatment of infectious diseases.
Business Model:
Revenue: $1M
Employees: 11-50
Address: 1682 Rue de la Valsière
City: Grabels
State: île-de-france
Zip: 34790
Country: FR
DEINOVE is a France-based biotechnology company that researches and develops antimicrobial therapies for the treatment of infectious diseases.
Contact Phone:
Contact Email:
Listed Exchange:
PA
IPO Date:
5/7/2010
Ticker Symbol:
ALDEI
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2006 | Funding Round | 1 | - |
Truffle Capital Truffle Capital |
12/2021 | Post-IPO Equity | $566.7k | 3/2020 | Post-IPO Equity | 1 | $1.7M |
Bpifrance Bpifrance |
3/2019 | Post-IPO Equity | 1 | $1.7M |
Bpifrance Bpifrance |
11/2009 | Grant | $9M | 11/2010 | Grant | $1.8M | 4/2010 | IPO | - | 4/2021 | Grant | - | 12/2019 | Grant | - | 4/2010 | IPO | - |
|
12/2021 | Post-IPO Equity | $566.7k | 3/2020 | Post-IPO Equity | 1 | $1.7M |
Bpifrance Bpifrance |
3/2019 | Post-IPO Equity | 1 | $1.7M |
Bpifrance Bpifrance |
1/2006 | Funding Round | 1 | - |
Truffle Capital Truffle Capital Truffle Capital Truffle Capital |
---|
Announced Date | Name | Price |
---|---|---|
4/2018 | Morphochem AG | |
3/2013 | Deinobiotics SAS |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|